Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 9,496 shares of the conglomerate’s stock, valued at approximately $6,838,000.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Clarion Wealth Managment Partners LLC acquired a new position in Danaher during the second quarter worth $590,000. Forefront Analytics LLC purchased a new position in shares of Danaher during the 2nd quarter worth $389,000. Elefante Mark B acquired a new position in shares of Danaher during the 2nd quarter valued at about $5,372,000. Matters Capital LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $226,000. Finally, Haverford Trust Co purchased a new stake in shares of Danaher in the second quarter valued at about $2,241,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
NYSE DHR opened at $219.42 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The stock has a 50-day moving average of $195.80 and a two-hundred day moving average of $192.40.
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, TD Cowen decreased their price target on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.
Check Out Our Latest Stock Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
